TY - JOUR
T1 - Usefulness of a prototype directional catheter for excimer laser coronary angioplasty in narrowings unfavorable for conventional excimer or balloon angioplasty
AU - Rechavia, Eldad
AU - Federman, Jack
AU - Shefer, Arie
AU - Macko, Gail
AU - Eigler, Neal L.
AU - Litvack, Frank
N1 - Funding Information:
From the Cardiovascular Cardiology, Department of Cedars-Sinai Medical Los Angeles, California. Save A Heart Foundation California, and he is Physicians Fellowship, June 6, 1995; revised 24, 1995. Address tion Center, Room 6558, Intervention Research Center, Division of of Medicine and Medical Research Institute Center and the UCLA School of Medicine, Dr. E. Rechavia is su ported in part by the Lillian Goldstein Fe Plo wship, Los Angeles, a recipient of fellowship from the American Brookline, Massachusetts. Manuscript received manuscript received and accepted August
PY - 1995/12/1
Y1 - 1995/12/1
N2 - We report clinical and angiographic results in 53 patients with 57 significant coronary or saphenous vein graft narrowings treated with directional excimer laser angioplasty. The target vessels were the left main (1%), anterior descending (32%), circumflex (19%), right coronary artery (39%), and vein grafts (9%). Lesions were morphologic class B1 (18%), B2 (79%), or C (3%), with 40 de novo and 17 restenotic lesions. Adjunctive balloon angioplasty was used in 53 lesions (93%). Mean pre- and postprocedural minimal lumen diameters were 0.6 ± 0.3 and 1.9 ± 0.7 mm (p < 0.001), corresponding to a mean diameter stenosis of 72 ± 20% and 27 ± 16%. Procedural success rate was 91%. Cumulative risk of death, Q-wave myocardial infarction, or emergency bypass operation was 9% (5 patients). Of patients who had a successful laser procedure, 28 (60%) with 30 lesions underwent angiographic follow-up at 6 ± 3 months after the procedure. Restenosis rates (>50% diameter restenosis or acute gain loss) were 37% and 23%, respectively. Four patients underwent bypass, 3 angioplasty, and 1 patient died from cancer. This study demonstrates the feasibility of directional application of laser energy to selected unfavorable narrowings for conventional excimer laser or balloon angioplasty. Further evaluation of this device using the now standard saline infusion technique is necessary to establish its ultimate role as a primary interventional device.
AB - We report clinical and angiographic results in 53 patients with 57 significant coronary or saphenous vein graft narrowings treated with directional excimer laser angioplasty. The target vessels were the left main (1%), anterior descending (32%), circumflex (19%), right coronary artery (39%), and vein grafts (9%). Lesions were morphologic class B1 (18%), B2 (79%), or C (3%), with 40 de novo and 17 restenotic lesions. Adjunctive balloon angioplasty was used in 53 lesions (93%). Mean pre- and postprocedural minimal lumen diameters were 0.6 ± 0.3 and 1.9 ± 0.7 mm (p < 0.001), corresponding to a mean diameter stenosis of 72 ± 20% and 27 ± 16%. Procedural success rate was 91%. Cumulative risk of death, Q-wave myocardial infarction, or emergency bypass operation was 9% (5 patients). Of patients who had a successful laser procedure, 28 (60%) with 30 lesions underwent angiographic follow-up at 6 ± 3 months after the procedure. Restenosis rates (>50% diameter restenosis or acute gain loss) were 37% and 23%, respectively. Four patients underwent bypass, 3 angioplasty, and 1 patient died from cancer. This study demonstrates the feasibility of directional application of laser energy to selected unfavorable narrowings for conventional excimer laser or balloon angioplasty. Further evaluation of this device using the now standard saline infusion technique is necessary to establish its ultimate role as a primary interventional device.
UR - http://www.scopus.com/inward/record.url?scp=0028804340&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(99)80324-5
DO - 10.1016/S0002-9149(99)80324-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 7484899
AN - SCOPUS:0028804340
SN - 0002-9149
VL - 76
SP - 1144
EP - 1146
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 16
ER -